Entity Type
Company
CIK 0001080014. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Entity Type
Company
Total Filings
1,660
Latest Filing
22 May 2026
Industry
Pharmaceutical Preparations
Save this filer to return when a new filing changes the portfolio, large-stake, insider, or company context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Best next click
Start with the summary below, then verify the strongest source-backed page for this filer.
4 filed on 22 May 2026 for CIK 0001080014.
Filer intelligence
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Counts show available parsed rows, not one combined ownership total.
ARMP
12 May 2026 · Common Stock, $0.01 par value
ETTX
08 Jul 2022 · 10% owner
ARMP
10 Jan 2023 · 10% owner
Latest update
Latest Schedule 13D/G period: 12 May 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
13 May 2026
Page type
Filer profile
Latest period
12 May 2026
Schedule 13D/G context is visible from filings filed on 13 May 2026.
Benchmark Context
Innoviva, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest Schedule 13D/G period: 12 May 2026. That gives you a fresh baseline before you compare this company with peers.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
Observed form types
Industry context: Pharmaceutical Preparations.
Recent SEC filings for Innoviva, Inc. with direct links to document and filing folders.